Acetazolamide and Gilenya drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Acetazolamide (acetazolamide) and Gilenya (fingolimod). Common drug interactions include dyspnoea among females and depression among males.

The phase IV clinical study analyzes what interactions people have when they take Acetazolamide and Gilenya. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Acetazolamide?

Acetazolamide has active ingredients of acetazolamide. It is often used in pseudotumor cerebri. eHealthMe is studying from 6,178 Acetazolamide users. Check the latest studies of Acetazolamide.

What is Gilenya?

Gilenya has active ingredients of fingolimod. It is often used in multiple sclerosis. eHealthMe is studying from 111,893 Gilenya users. Check the latest studies of Gilenya.

On Aug, 03, 2026

22 people who take Acetazolamide and Gilenya together, and have interactions are studied.

Acetazolamide and Gilenya drug interactions.

What are the common drug interactions of Acetazolamide and Gilenya, by gender? *:

female:

Dyspnoea (difficult or laboured respiration)
Furuncle (infection of the hair follicle)
Gastric disorder (disease of stomach)
Heart rate increased
Herpes zoster
Meningitis cryptococcal (bacterial inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
Rash
Spinal pain (pain in spine)
Tremor (trembling or shaking movements in one or more parts of your body)
Headache (pain in head)

male:

Depression
Fatigue (feeling of tiredness)
Ataxia (loss of full control of bodily movements)
Blood glucose increased
Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
Choking (mechanical obstruction of the flow of air from the environment into the lungs)
Demyelination (loss of the myelin covering of some nerve fibres resulting in their impaired function)
Dysarthria (speech disorder)
Dysphagia (a condition in which swallowing is difficult or painful)
Gait disturbance

What are the common drug interactions of Acetazolamide and Gilenya, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Basedow's disease (autoimmune disease where the thyroid is overactive, producing an excessive amount of thyroid hormones)
Blindness unilateral
Bradycardia (abnormally slow heart action)
C-reactive protein increased
Diplopia (double vision)
Endocrine ophthalmopathy (increased water content of retroocular orbital tissues; associated with thyroid disease, usually hyperthyroidism)
Fatigue (feeling of tiredness)
Feeling hot
Fungal infection
Headache (pain in head)

40-49:

Demyelination (loss of the myelin covering of some nerve fibres resulting in their impaired function)
Dysarthria (speech disorder)
Aphasia (damage to the parts of the brain that control language)
Asthenia (weakness)
Csf pressure increased
Diplopia (double vision)
Eye movement disorder
Hallucination, auditory (perceiving sounds without auditory stimulus)
Hallucination, visual (seeing things that aren't there)
Headache (pain in head)

50-59:

Aphasia (damage to the parts of the brain that control language)
Blood pressure increased
Nausea (feeling of having an urge to vomit)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Somnolence (a state of near-sleep, a strong desire for sleep)
Stress
Vomiting
Balance disorder
Gait disturbance
Gastroenteritis (inflammation of stomach and intestine)

60+:

n/a

What are the existing conditions these people have? *

Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 18.18%
Flatulence (flatus expelled through the anus): 4 people, 18.18%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 4 people, 18.18%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 13.64%
Quit Smoking: 2 people, 9.09%
Glaucoma (increased fluid pressure in the eye with vision loss): 2 people, 9.09%
Diabetes: 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Acetazolamide and Gilenya?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously